MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
3. Government ... Funders, Regulators, Policy Makers, Conveners
*Government: International
Europe
*Europe: Regions
*Western Europe
Ireland
*Industry: Ireland
Alkermes plc (NASDAQ:ALKS)
Finance & Acquisitions: Alkermes
Parents
Alkermes plc (NASDAQ:ALKS)
Children
2011: Alkermes Acquires Elan Drug Manufacturing Unit for $960M (2011)
2014: Alkermes Nabs $250M It Doesn’t Need, But Could Fend Off Barbarians (2014)
2022: Alkermes Inspiration Grants®
2022: Alkermes plc 2022 Q3 - Results - Earnings Call Presentation_ seekingalpha.com
2024: Alkermes plc 2023 Q4 - Results - Earnings Call Presentation
2025: Alkermes plc 2024 Q4 - Results - Earnings Call Presentation
Alkermes has an equity stake in the startup and granted a license to the inhaled drug-delivery technology to Civitas
Alkermes plc Ordinary Shares (ALKS) Analyst Research
ALKS, Alkermes Plc
Elan Corporation, plc (NYSE: ELN)
Revenue US $1.1 billion (2022)
Revenue: 1 billion USD (2018)
Jumps
*Key People: Alkermes
Organization & Developments: Alkermes